Figure 6
Figure 6. PD-L knockdown DCs boost the proliferative capacity and function of MiHA-specific CD8+ memory T cells. Two days after electroporation with PD-L1 and/or PD-L2 siRNA, mature HLA-B7+LRH-1− DCs were loaded with or without 5μM LRH-1 peptide. PD-L knockdown resulted in < 5% PD-L1+ and/or < 2% PD-L2+ DCs. (A) PBMCs of patient UPN389, consecutively stimulated with PD-L knockdown DCs at a ratio of 1:0.1, were weekly screened for tetramer+ CD8+ T cells using flow cytometry. The numbers in the FACS plots represent the percentage of LRH-1–specific CD8+ T cells in the total CD3+CD8+ T-cell population. Data are representative for 2 independent experiments. (B) Cumulative numbers of LRH-1–specific CD8+ T cells of patient UPN389 obtained after 3 consecutive stimulations with PD-L knockdown DCs loaded with or without LRH-1 peptide. (C) Percentage of LRH-1–specific CD8+ T cells in PBMCs of patient UPN543. PBMCs were consecutively stimulated with PD-L knockdown DCs at a ratio of 1:0.1 and weekly screened for tetramer+ CD8+ T cells using flow cytometry. (D) Cumulative numbers of LRH-1–specific CD8+ T cells of patient UPN543 obtained after 2 consecutive stimulations with PD-L knockdown DCs loaded with or without LRH-1 peptide. (E) Degranulation of LRH-1–specific CD8+ T cells of patient UPN389, stimulated for 2 weeks with LRH-1 peptide-loaded PD-L knockdown DC, was measured by staining for CD107a during overnight stimulation with different target cells. PBMCs were cultured 1:1 with LRH-1− donor EBV-LCL, LRH-1 peptide-loaded donor EBV-LCL, LRH-1+ recipient EBV-LCL, or in medium. ND indicates not determined.

PD-L knockdown DCs boost the proliferative capacity and function of MiHA-specific CD8+ memory T cells. Two days after electroporation with PD-L1 and/or PD-L2 siRNA, mature HLA-B7+LRH-1 DCs were loaded with or without 5μM LRH-1 peptide. PD-L knockdown resulted in < 5% PD-L1+ and/or < 2% PD-L2+ DCs. (A) PBMCs of patient UPN389, consecutively stimulated with PD-L knockdown DCs at a ratio of 1:0.1, were weekly screened for tetramer+ CD8+ T cells using flow cytometry. The numbers in the FACS plots represent the percentage of LRH-1–specific CD8+ T cells in the total CD3+CD8+ T-cell population. Data are representative for 2 independent experiments. (B) Cumulative numbers of LRH-1–specific CD8+ T cells of patient UPN389 obtained after 3 consecutive stimulations with PD-L knockdown DCs loaded with or without LRH-1 peptide. (C) Percentage of LRH-1–specific CD8+ T cells in PBMCs of patient UPN543. PBMCs were consecutively stimulated with PD-L knockdown DCs at a ratio of 1:0.1 and weekly screened for tetramer+ CD8+ T cells using flow cytometry. (D) Cumulative numbers of LRH-1–specific CD8+ T cells of patient UPN543 obtained after 2 consecutive stimulations with PD-L knockdown DCs loaded with or without LRH-1 peptide. (E) Degranulation of LRH-1–specific CD8+ T cells of patient UPN389, stimulated for 2 weeks with LRH-1 peptide-loaded PD-L knockdown DC, was measured by staining for CD107a during overnight stimulation with different target cells. PBMCs were cultured 1:1 with LRH-1 donor EBV-LCL, LRH-1 peptide-loaded donor EBV-LCL, LRH-1+ recipient EBV-LCL, or in medium. ND indicates not determined.

Close Modal

or Create an Account

Close Modal
Close Modal